Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis Apre una nuova scheda del browser
(2013)
Inizio contenuto principale del sito
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)